LEIF MARZ: Open Payments
NPI 1659982726 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 33 payments from 6 companies in 2025. Trend: 2023 $3,350 · 2024 $2,964 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $248 |
| ViiV Healthcare Company | 5 | $164 |
| ABBVIE INC. | 10 | $164 |
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Merck Sharp & Dohme LLC | 2 | $47 |
Products named: DOVATO, VRAYLAR, ABILIFY MAINTENA, Biktarvy, JARDIANCE, Vemlidy, PIFELTRO, DALVANCE.
Industry payments across HI — which companies pay providers there.
